))
The difficulty in comparing SARS-CoV2 vaccines
Manage episode 333582416 series 3368689
Content provided by Tim Pilcher. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tim Pilcher or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Further reading/resources:
- Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines (JAMA Network)
- SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn (American College of Cardiology)
- Handicapping the COVID Vaccine Horse Race (Medscape)
- New COVID-19 vaccine trials starting in children (MSN)
- Pfizer says its Covid vaccine trial for kids ages 12 to 15 is fully enrolled (CNBC)
- South Africa Halts AstraZeneca Vaccine Rollout Over Effectiveness Doubts With New Variant (Slate)
171 episodes
Share
